• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[200例支气管肺化脓症的卡那霉素雾化吸入疗法]

[KANAMYCIN AEROSOL THERAPY IN 200 CASES OF BRONCHOPULMONARY SUPPURATIONS].

作者信息

BILODEAU M, ROY J

出版信息

Can Med Assoc J. 1963 Sep 14;89(11):537-41.

PMID:14045345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1921807/
Abstract

This paper describes the results obtained in 200 patients with bronchopulmonary suppurative diseases who received kanamycin aerosol therapy under intermittent positive pressure and in whom bacterial sensitivity study (antibiogram) was favourable. This method of treatment was well tolerated and was practically free of side effects. In most cases the improvement was rapid, was maintained and was often life-saving. The first series contained nine patients with pulmonary tuberculosis and a constant finding of sputum positive for Koch bacillus; four of these became negative after eight weeks of treatment. This suggested that kanamycin aerosol therapy had some effect on the Koch bacillus and that the study should be continued with a much larger group of patients with tuberculous suppurative pulmonary diseases to determine the efficacy of this antibiotic.

摘要

本文描述了200例支气管肺化脓性疾病患者接受间歇正压下卡那霉素雾化治疗的结果,这些患者的细菌敏感性研究(抗生素敏感性试验)结果良好。这种治疗方法耐受性良好,几乎没有副作用。在大多数情况下,病情改善迅速,得以维持,且常常挽救生命。第一组有9例肺结核患者,痰中持续检出结核杆菌;其中4例在治疗8周后转阴。这表明卡那霉素雾化治疗对结核杆菌有一定作用,应继续对更多患有结核性化脓性肺病的患者进行研究,以确定这种抗生素的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/57667a918a5d/canmedaj01013-0009-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/11166926a67f/canmedaj01013-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/c38e4c8657e0/canmedaj01013-0007-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/5524914ad115/canmedaj01013-0007-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/cf76558da13e/canmedaj01013-0007-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/a3a9a5968573/canmedaj01013-0008-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/3b476d9e692a/canmedaj01013-0008-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/c90e345b5d8f/canmedaj01013-0008-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/57762fd4a8e3/canmedaj01013-0008-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/93f641118654/canmedaj01013-0009-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/57667a918a5d/canmedaj01013-0009-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/11166926a67f/canmedaj01013-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/c38e4c8657e0/canmedaj01013-0007-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/5524914ad115/canmedaj01013-0007-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/cf76558da13e/canmedaj01013-0007-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/a3a9a5968573/canmedaj01013-0008-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/3b476d9e692a/canmedaj01013-0008-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/c90e345b5d8f/canmedaj01013-0008-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/57762fd4a8e3/canmedaj01013-0008-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/93f641118654/canmedaj01013-0009-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5463/1921807/57667a918a5d/canmedaj01013-0009-b.jpg

相似文献

1
[KANAMYCIN AEROSOL THERAPY IN 200 CASES OF BRONCHOPULMONARY SUPPURATIONS].[200例支气管肺化脓症的卡那霉素雾化吸入疗法]
Can Med Assoc J. 1963 Sep 14;89(11):537-41.
2
[SPONTANEOUS PNEUMOTHORAX].[自发性气胸]
Torax. 1964 Jun;13:59-62.
3
[Post-tuberculosis syndromes in a pneumology unit].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1977 Oct-Dec;26(4):211-6.
4
INCIDENCE AND SIGNIFICANCE OF FUNGI IN SPUTUM IN BRONCHOPULMONARY DISEASES.支气管肺部疾病痰液中真菌的发生率及意义
Acta Tuberc Pneumol Scand. 1964;45:295-300.
5
[INCIDENCE OF PULMONARY TUBERCULOSIS AND OTHER DISEASES OF THE RESPIRATORY SYSTEM IN THE ARAB POPULATION OF CYRENAICA DURING THE 2-YEAR PERIOD FROM JULY 1959 TO JULY 1961].[1959年7月至1961年7月这两年期间昔兰尼加阿拉伯人群中肺结核及其他呼吸系统疾病的发病率]
Lotta Tuberc. 1963 Jul-Aug;33:416-37.
6
[ON THE USE OF PROTEOLYTIC ENZYMES IN ASSOCIATION WITH ANTIMYCOBACTERIAL AGENTS IN THE THERAPY OF DISEASES OF THE RESPIRATORY SYSTEM].
Rass Clin Ter. 1964;63:45-62.
7
BRONCHIECTASIS AND CHRONIC PULMONARY SUPPURATION.
Mod Treat. 1964 Mar;1:262-72.
8
[The continuing prevalence of suppurative bronchopneumopathies].
Ftiziologia. 1972 Nov-Dec;21(6):629-44.
9
CORRELATION BETWEEN RADIOLOGICAL DIAGNOSIS AND STRUCTURAL LUNG CHANGES IN EMPHYSEMA.肺气肿的影像学诊断与肺结构改变之间的相关性
Clin Radiol. 1964 Oct;15:307-11. doi: 10.1016/s0009-9260(64)80002-7.
10
[CLINICAL OBSERVATIONS ON THE ACTIVITY OF AEROSOL COLIMYCIN AND OF ENDOBRONCHIAL INSTILLATIONS OF COLIMYCIN IN PATIENTS WITH PULMONARY SUPPURATIONS].[气溶菌素及肺脓肿患者支气管内注入粘菌素活性的临床观察]
Minerva Med. 1963 Jul 21;54:2117-22.

引用本文的文献

1
[Therapeutic functions of a center of inhalation therapy: aerosol therapy].
Can Anaesth Soc J. 1968 Nov;15(6):610-27. doi: 10.1007/BF03004357.